In a 31‑year‑old female presenting with a typical migraine headache and new bilateral wrist and ankle arthralgias, what are the possible diagnoses and recommended next steps?

Differential Diagnosis and Management

This patient requires urgent evaluation for a systemic inflammatory or autoimmune condition, most likely viral arthritis or early connective tissue disease, given the acute onset of symmetric polyarticular joint pain accompanying her typical migraine pattern.

Primary Diagnostic Considerations

Most Likely Diagnoses

• Viral arthritis with concurrent migraine: The recent history of viral illness with rashes, combined with acute bilateral symmetric joint involvement (wrists and ankles), strongly suggests post-viral or para-viral arthropathy 1
• Early systemic lupus erythematosus (SLE): Young woman with migraine history, new polyarticular arthritis, and prior viral-like illness with rash warrants consideration of SLE, which commonly presents with these features
• Reactive arthritis: Following viral illness, though typically affects lower extremity large joints more than wrists
• Medication overuse headache (MOH): Patient discontinued flunarizine 5 months ago and may be overusing acute medications, though the joint symptoms suggest a broader systemic process 2

Critical Red Flags Assessment

The patient does not exhibit concerning secondary headache red flags per established criteria 2:

• No thunderclap onset
• No atypical aura features
• No focal neurological symptoms on examination
• Normal fundoscopy (excludes papilledema)
• No fever, neck stiffness, or altered consciousness
• Age <50 years
• Headache pattern matches her established migraine phenotype

However, the new joint symptoms represent a significant change requiring investigation beyond headache management.

Immediate Next Steps

Essential Laboratory Workup

Order the following tests urgently to evaluate for systemic inflammatory/autoimmune conditions:

• Complete blood count with differential: Assess for cytopenias (especially lymphopenia and thrombocytopenia seen in SLE)
• Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP): Markers of systemic inflammation
• Antinuclear antibody (ANA) with reflex panel: Screen for SLE and other connective tissue diseases
• Rheumatoid factor (RF) and anti-CCP antibodies: Evaluate for rheumatoid arthritis, though less likely given acute onset
• Comprehensive metabolic panel: Assess renal function (lupus nephritis consideration)
• Urinalysis with microscopy: Screen for proteinuria, hematuria, or cellular casts
• Viral serologies: Consider parvovirus B19, EBV, and other arthritogenic viruses given recent viral illness

Clinical Examination Focus

Perform targeted assessment for:

• Skin examination: Look for malar rash, discoid lesions, photosensitivity, oral ulcers (SLE features)
• Joint examination: Document specific joints involved, presence of effusion, warmth, or erythema
• Systemic review: Assess for Raynaud's phenomenon, alopecia, serositis symptoms

Migraine Management During Workup

Acute Treatment Optimization

For this current migraine attack, offer NSAIDs as first-line therapy 2:

• Ibuprofen 400-600 mg or diclofenac potassium 50-100 mg
• This also addresses joint inflammation if inflammatory arthritis is present
• Add metoclopramide 10 mg for nausea/vomiting 2

If NSAIDs fail, advance to triptan therapy 2:

• Sumatriptan 50-100 mg orally or 6 mg subcutaneously for rapid relief
• Advise early use when headache is still mild for optimal efficacy 2

Preventive Treatment Consideration

The patient requires reinitiation of migraine prophylaxis given:

• First episode in 5 months suggests inadequate control
• Discontinued flunarizine without alternative prophylaxis 2
• Risk of medication overuse with frequent acute treatment 2

However, defer preventive medication decisions until systemic workup is complete, as:

• Underlying autoimmune condition may influence drug selection
• Some preventive agents (e.g., beta-blockers) may interact with potential treatments for connective tissue disease
• If SLE is diagnosed, hydroxychloroquine would address both conditions

Follow-Up Timeline

• Laboratory results review: 24-48 hours
• Rheumatology referral: Within 1-2 weeks if ANA positive or inflammatory markers elevated
• Neurology follow-up: 2-4 weeks to reassess migraine control and optimize prophylaxis once systemic diagnosis clarified

Critical Pitfalls to Avoid

• Do not attribute joint symptoms solely to migraine-associated phenomena: While migraine has comorbidities, acute polyarticular arthritis is not among them 2
• Do not restart migraine prophylaxis without systemic evaluation: The joint symptoms mandate investigation before committing to long-term therapy
• Do not perform neuroimaging: No red flags present to justify MRI/CT 2, 3
• Do not prescribe opioids or barbiturates: These are ineffective for migraine and risk dependency 2
• Avoid medication overuse: Counsel patient that frequent acute medication use (>10 days/month for triptans, >15 days/month for simple analgesics) risks MOH 2

Patient Education

Explain that:

• Her headache pattern remains consistent with migraine and does not suggest dangerous secondary causes 2
• The joint symptoms require separate evaluation for inflammatory or autoimmune conditions
• Blood tests will guide whether rheumatology consultation is needed
• Migraine prophylaxis will be optimized once systemic evaluation is complete
• She should track headache frequency and acute medication use to assess for MOH risk 2